Skip to main content

Table 2 HLA DR allelic frequencies between RHD cases and non RHD controls

From: Rheumatic heart disease in Uganda: the association between MHC class II HLA DR alleles and disease: a case control study

Variable

Total (n,%)

Cases (n,%)

Controls (n,%)

P value

HLA

DR1

45/199, 22.6%

14/96, 14.6%

31/103, 30.1%

0.01

 

DR3

18/199,9.04%

7/96, 7.29%

11/103, 10.7%

0.4

 

DR7

16/199, 8.04%

11/96, 11.5%

5/103, 4.9%

0.1

 

DR8

11/199, 5.53%

4/96, 4.2%

7/103, 6.8%

0.34

 

DR9

7/199, 3.52%

4/96, 4.2%

3/103, 2.9%

0.36

 

DR10

8/199, 4.02%

6/96, 6.3%

2/103, 1.9%

0.13

 

DR11

41/199,20.60%

30/96, 31.3%

11/103, 10.7%

<0.001

 

DR13

11/199, 5.53%

4/96, 4.2%

7/103, 6.8%

0.47

 

DR17

24/199,12.06%

9/96, 9.4%

15/103, 14.6%

0.28

  1. HLA- Human leukocyte antigen.